title: The importance of functional tests in personalized medicine.
abstract: Cardiovascular disease is the most prevalent disease mainly in the Western society and becoming the leading cause of death worldwide. Standard methods by which healthcare providers screen for cardiovascular disease have only minimally reduced the burden of disease while exponentially increasing costs. As such, more specific and individualized methods for functionally assessing cardiovascular threats are needed to identify properly those at greatest risk, and appropriately treat these patients so as to avoid a fate such as heart attack, stroke, or death. Currently, endothelial function testing-in both the coronary and peripheral circulation-is well established as being associated with the disease process and future cardiovascular events. Improving such testing can lead to a reduction in the risk of future events. Combining this functional assessment of vascular fitness with other, more personalized, testing methods should serve to identify those at the greatest risk of cardiovascular disease earlier and subsequently reduce the affliction of such diseases worldwide.
authors.affiliation: Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and College of Medicine, Rochester, MN, USA.
authors.forename: R Jay
authors.initials: RJ
authors.lastname: Widmer
authors.forename: Amir
authors.initials: A
authors.lastname: Lerman
keywords: Cardiovascular disease; endothelial function; individualized medicine
references.citation: J Am Coll Cardiol. 2010 Nov 23;56(22):1840-6
references.pmid: 21087714
references.citation: J Am Coll Cardiol. 2002 Aug 7;40(3):505-10
references.pmid: 12142118
references.citation: Circ J. 2008 May;72(5):778-85
references.pmid: 18441459
references.citation: J Am Coll Cardiol. 2009 Jan 27;53(4):323-30
references.pmid: 19161880
references.citation: Eur Heart J. 2010 May;31(9):1142-8
references.pmid: 20181680
references.citation: Clin Auton Res. 2008 Dec;18(6):339-45
references.pmid: 18850310
references.citation: Eur Heart J. 2011 Apr;32(8):1006-11
references.pmid: 21196446
references.citation: Lancet. 1991 Sep 14;338(8768):660-1
references.pmid: 1679475
references.citation: BMJ. 2002 Dec 21;325(7378):1439-42
references.pmid: 12493655
references.citation: Circulation. 2011 Jan 18;123(2):163-9
references.pmid: 21200002
references.citation: JAMA. 1995 Jul 12;274(2):131-6
references.pmid: 7596000
references.citation: Circulation. 2002 Sep 3;106(10):1189-91
references.pmid: 12208790
references.citation: Circulation. 1996 Jun 15;93(12):2106-13
references.pmid: 8925578
references.citation: Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2113-9
references.pmid: 17717291
references.citation: Am Heart J. 2009 Jan;157(1):111-117.e2
references.pmid: 19081406
references.citation: JACC Cardiovasc Interv. 2011 Nov;4(11):1175-82
references.pmid: 22035875
references.citation: N Engl J Med. 2009 Jan 15;360(3):213-24
references.pmid: 19144937
references.citation: Chest. 2005 Aug;128(2):810-5
references.pmid: 16100172
references.citation: Circulation. 1996 Aug 15;94(4):614-21
references.pmid: 8772679
references.citation: Circulation. 2011 Apr 12;123(14):1545-51
references.pmid: 21444885
references.citation: N Engl J Med. 2007 Apr 12;356(15):1503-16
references.pmid: 17387127
references.citation: Circulation. 2009 Aug 11;120(6):502-9
references.pmid: 19635967
references.citation: Circulation. 1996 Mar 1;93(5):924-31
references.pmid: 8598083
references.citation: Circulation. 1996 Jan 1;93(1):34-41
references.pmid: 8616937
references.citation: Am Heart J. 1999 May;137(5):830-6
references.pmid: 10220631
references.citation: Circulation. 2008 Mar 11;117(10):1283-91
references.pmid: 18268144
references.citation: N Engl J Med. 1986 Oct 23;315(17):1046-51
references.pmid: 3093861
references.citation: N Engl J Med. 2004 Apr 8;350(15):1495-504
references.pmid: 15007110